ARTICLE | Company News
Kinetek, Tyrogene Biotechnologies Inc. deal
March 13, 2000 8:00 AM UTC
Kinetek acquired Tyrogene Biotechnologies, a cancer company developing inhibitors of protein tyrosine phosphatase signaling proteins. Kinetek is developing drugs for signal transduction-related disea...